Last reviewed · How we verify
NCT05054881: EPBwEPN
Effectiveness of Peripheral Blocks Under Ultrasound Control With and Without Electrical Nerve Stimulation
NA trial testing sciatic nerve blockade under ultrasound control with a peripheral nerve stimulator in Nerve Block in 40 participants. Completed in 13 July 2022.
13 July 2022
Quick facts
| Lead sponsor | Mogilev Regional Clinical Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | other |
| Enrollment | 40 |
| Start date | 4 April 2022 |
| Primary completion | 13 July 2022 |
| Estimated completion | 13 July 2022 |
| Sites | 1 location across Belarus |
Drugs / interventions tested
- sciatic nerve blockade under ultrasound control with a peripheral nerve stimulator
- sciatic nerve blockade under ultrasound control without a peripheral nerve stimulator
Conditions studied
- Nerve Block — all drugs for Nerve Block →
- Efficiency — all drugs for Efficiency →
- Sciatic Nerve — all drugs for Sciatic Nerve →
- Ultrasonography — all drugs for Ultrasonography →
Sponsor
Mogilev Regional Clinical Hospital
Who can join
Adults 18 to 90, any sex, with Nerve Block or Efficiency. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In modern anesthesiology, peripheral nerve blocks are performed using ultrasound control and electrical stimulation of peripheral nerves (PEN), or only ultrasound control or only PEN. The most effective methods are with the use of ultrasound control. Until now, the effectiveness of the sciatic nerve blockade by the subgluteal approach, performed only under ultrasound control without ESP, in comparison with the blockade of the sciatic nerve performed under ultrasound control with ESP, has not been established. Research hypothesis: the blockade of the sciatic nerve by the subgluteal approach performed only under ultrasound control has the same effectiveness as the blockade performed under the ultrasound control with EPN.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05054881
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Nerve Block
Currently open trials in the same condition.
- NCT07509866 — Liposomal Bupivacaine Versus Ropivacaine With Perineural Dexamethasone or Dexmedetomidine as Adjuncts for Adductor Canal · NA · recruiting
- NCT07346885 — Lumbar-Sacral Plexus Block vs Fascia Iliaca Block Plus Low-Dose Spinal Anesthesia for Femoral Neck Fracture Surgery · NA · active not recruiting
- NCT07249827 — A Randomized Comparison Between 0.67 mcg/kg, 1 mcg/kg, and 1.33 mcg/kg of Perineural Dexmedetomidine for Ultrasound-Guid · Phase 2 · recruiting
- NCT07239817 — PENG Block + LIA For Endoprosthesis Surgery With Anterior Approach · NA · recruiting
- NCT07510269 — Investigation of the Effects of Serratus Posterior Superior Intercostal Plane Block and Serratus Anterior Plane Block on · NA · recruiting
Other Mogilev Regional Clinical Hospital trials
Trials by the same sponsor.
- NCT05209490 — Ultrasound-guided Femoral Nerve Block Without Electrical Stimulation of Peripheral Nerves · NA · completed
- NCT05209711 — Femoral Nerve Blockade 7.5 ml of 1% Lidocaine: US Guidance Versus US Guidance With Electrical Stimulation of Peripheral · NA · unknown
- NCT05205473 — Sciatic Nerve Blockade by Subgluteal Access 12.5 ml of 1% Lidocaine: US Guidance Versus US Guidance With Electrical Stim · NA · completed
- NCT05184465 — Comparison of the Efficacy of 0.5% Bupivacaine, 0.5% Levobupivacaine, and 0.5% Hyperbaric Bupivacaine · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05054881 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Mogilev Regional Clinical Hospital
- Last refreshed: 9 August 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05054881.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing